Department of Anaesthesiology, University Hospital of Larissa, Mezourlo, 41110, Larissa, Greece.
Department of Surgery, General Hospital of Volos, Polymeri 134, 38222, Volos, Greece.
Langenbecks Arch Surg. 2023 May 18;408(1):197. doi: 10.1007/s00423-023-02937-x.
PURPOSE: We designed this study to evaluate the impact of intraoperative intravenous lidocaine infusion on postoperative opioid consumption after laparoscopic cholecystectomy. METHODS: In total, 98 patients scheduled for elective laparoscopic cholecystectomy were included and randomized. In the experimental group, intravenous lidocaine (bolus 1.5 mg/kg and continuous infusion 2 mg/kg/h) was administered intraoperatively additionally to the standard analgesia, whereas the control group received a matching placebo. Blinding existed at the level of both the patient and the investigator. RESULTS: Our study failed to confirm any benefit in opioid consumption, during the postoperative period. Lidocaine resulted to reduced intraoperative systolic, diastolic, and mean arterial pressure. Lidocaine administration did not change postoperative pain scores or the incidence of shoulder pain, at any time endpoint. Moreover, we did not identify any difference in terms of postoperative sedation levels and nausea rates. CONCLUSION: Overall, lidocaine did not have any effect on postoperative analgesia after laparoscopic cholecystectomy.
目的:我们设计本研究旨在评估腹腔镜胆囊切除术患者术中静脉注射利多卡因对术后阿片类药物消耗的影响。
方法:共纳入 98 例行择期腹腔镜胆囊切除术的患者,并进行随机分组。实验组在标准镇痛的基础上额外给予静脉注射利多卡因(负荷量 1.5mg/kg,持续输注 2mg/kg/h),而对照组给予匹配的安慰剂。患者和研究者均设为双盲。
结果:我们的研究未能证实术后阿片类药物消耗有任何获益。利多卡因可降低术中收缩压、舒张压和平均动脉压。利多卡因的应用并未改变任何时间点的术后疼痛评分或肩痛发生率。此外,我们在术后镇静水平和恶心发生率方面也未发现任何差异。
结论:总体而言,利多卡因对腹腔镜胆囊切除术后的镇痛效果没有影响。
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2022-7-13
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2022-7-13
Cochrane Database Syst Rev. 2018-6-4
Ann Hepatobiliary Pancreat Surg. 2024-8-31
J Minim Access Surg. 2024-7-1
Surg Laparosc Endosc Percutan Tech. 2020-12